Amytal Sodium

Bausch Health US, LLC🇺🇸 United States

FDA Page

Effective Date: Jul 1, 2020
Approval ID: a2523317-e071-4e04-9d9f-9053286e0ce2
Products: 1 registered
Version: 8

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

AMYTAL SODIUM CII (amobarbital sodium) FOR INJECTION, USP Vials CAUTION: These products are to be used under the direction of a physician. The intravenous administration of AMYTAL SODIUM (amobarbital sodium) FOR INJECTION, USP carries with it the potential dangers inherent in the intravenous use of any potent hypnotic.

Quick Stats

Total Products1

Labelers2

Label Sections13

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.